000 01997nam  2200289za 4500
0019.691250
003CaOODSP
00520200401081926
007cr |||||||||||
008150407s2008||||onca||||o    f000 0 eng d
020 |a978-1-100-10267-2
040 |aCaOODSP|beng
043 |an-cn---
0861 |aH164-91/2008E-PDF
1101 |aCanada. |bHealth Canada. |bHealth Products and Food Branch.
24510|aDescription of current risk communication documents for marketed health products for human use |h[electronic resource].
260 |aOttawa : |bHealth Canada, |cc2008.
300 |aii, 42 p. :|bcol. ill.
4901 |aGuidance document
500 |aIssued also in French under title: Description des documents actuels de communication des risques concernant les produits de santé commercialisés destinés aux humains.
504 |aIncludes bibliographical references.
516 |aElectronic monograph in PDF format.
520 |a"Guidance documents are meant to provide assistance to industry and stakeholders on how to comply with governing statutes and regulations. Guidance documents also provide assistance to staff on how Health Canada's mandates and objectives should be implemented in a manner that is fair, consistent and effective. ... This guidance document provides information on the considerations for issuing one or several ofthe current thirteen (13) risk communication documents (section 5) regarding health products available on the Canadian market and that fall under the regulatory oversight of the Health Products and Food Branch"--p. i and p. 2.
590 |a08-51|b2008-12-24
77508|tDescription des documents actuels de communication des risques concernant les produits de santé commercialisés destinés aux humains : |w(CaOODSP)9.635583
830#0|aGuidance document (Canada. Health Canada)|w(CaOODSP)9.849006
85640|ahttp://publications.gc.ca|qPDF|s283 KB|uhttp://publications.gc.ca/collections/collection_2008/hc-sc/H164-91-2008E.pdf